Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Adenocarcinoma"" wg kryterium: Temat


Starter badań:

Tytuł :
Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
Autorzy :
Reynolds IS; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland. Electronic address: .
Cromwell PM; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Hoti E; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Pokaż więcej
Źródło :
American journal of surgery [Am J Surg] 2021 Sep; Vol. 222 (3), pp. 529-535. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Adenocarcinoma, Mucinous*/mortality
Adenocarcinoma, Mucinous*/pathology
Adenocarcinoma, Mucinous*/secondary
Adenocarcinoma, Mucinous*/surgery
Colonic Neoplasms*/mortality
Colonic Neoplasms*/pathology
Colonic Neoplasms*/secondary
Colonic Neoplasms*/surgery
Hepatectomy*
Rectal Neoplasms*/mortality
Rectal Neoplasms*/pathology
Rectal Neoplasms*/secondary
Rectal Neoplasms*/surgery
Liver Neoplasms/*mortality
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/secondary ; Adenocarcinoma/surgery ; Age Factors ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Databases, Factual ; Female ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/pathology ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Male ; Sex Factors
Czasopismo naukowe
Tytuł :
Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before.
Autorzy :
Yang ST; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Chang WH; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee NR; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
Lai WA; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taiwan.
Shen SH; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Radiology, Taipei Veterans General Hospital, Taiwan.
Lee WL; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan; Department of Nursing, Oriental Institute of Technology, New Taipei City, Taiwan. Electronic address: .
Wang PH; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Female Cancer Foundation, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Taiwanese journal of obstetrics & gynecology [Taiwan J Obstet Gynecol] 2021 Nov; Vol. 60 (6), pp. 1112-1115.
Typ publikacji :
Case Reports
MeSH Terms :
Adenocarcinoma, Mucinous/*diagnosis
Carcinoma, Endometrioid/*diagnosis
Carcinoma, Ovarian Epithelial/*diagnosis
Ovarian Neoplasms/*diagnosis
Adenocarcinoma, Clear Cell ; Adenocarcinoma, Mucinous/pathology ; Adenocarcinoma, Mucinous/therapy ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/therapy ; Carcinoma, Ovarian Epithelial/pathology ; Carcinoma, Ovarian Epithelial/therapy ; Cisplatin/therapeutic use ; Endometriosis/complications ; Female ; Humans ; Laparotomy ; Middle Aged ; Ovarian Cysts/pathology ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/therapy ; Paclitaxel/therapeutic use ; Treatment Outcome
Raport
Tytuł :
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials.
Autorzy :
Liu DHW; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Šefčovičová N; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.
Emmerson J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Spaans LN; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Maxima Medical Centre, Eindhoven/Veldhoven, the Netherlands.
Saito Y; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Hutchins G; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Nankivell MG; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Langley RE; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Allum W; Department of Oncology and Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Cunningham D; Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
Langer R; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Grabsch HI; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 140-148. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Clinical Trial, Phase III; Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma, Mucinous*/pathology
Esophageal Neoplasms*/pathology
Humans ; Mucins/therapeutic use ; Neoadjuvant Therapy ; Prognosis ; United Kingdom
SCR Disease Name :
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł :
Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Autorzy :
Sánchez-Cuerda C; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Cuadra M; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Gámir S; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Lobo P; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Elices M; Department of Pathology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Cabrera Y; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Pokaż więcej
Źródło :
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2022 Jul; Vol. 158 (1), pp. 21-26. Date of Electronic Publication: 2021 Oct 23.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Adenocarcinoma*/diagnosis
Adenocarcinoma*/surgery
Adenocarcinoma in Situ*/surgery
Cervical Intraepithelial Neoplasia*/diagnosis
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/surgery
Adult ; Conization/methods ; Female ; Humans ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Visceral obesity is associated with an increased risk of developing esophago-gastric junctional adenocarcinoma in Japan: a population-based case-control study in Akita Prefecture.
Autorzy :
Watanabe K; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. .
Koizumi S; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Shirane K; Shirane Hospital, Akita, Japan.
Tsuda H; Department of Gastroenterology, Akita Kousei Medical Center, Akita, Japan.
Watanabe H; Department of Gastroenterology, Akita Kousei Medical Center, Akita, Japan.
Tsuji T; Department of Gastroenterology, Akita City Hospital, Akita, Japan.
Onochi K; Department of Gastroenterology, Omagari Kosei Medical Center, Akita, Japan.
Yamai K; Department of Gastroenterology, Odate Municipal General Hospital, Akita, Japan.
Kusano C; Department of Gastroenterology, Yuri Kumiai General Hospital, Akita, Japan.; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
Dohmen T; Department of Gastroenterology, Yuri Kumiai General Hospital, Akita, Japan.
Horikawa Y; Department of Gastroenterology, Hiraka General Hospital, Akita, Japan.
Ajimine T; Department of Gastroenterology, Northern Akita Municipal Hospital, Akita, Japan.
Saito M; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Koike T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Shimodaira Y; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Matsuhashi T; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Iijima K; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Pokaż więcej
Źródło :
Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2022 Jul; Vol. 19 (3), pp. 477-485. Date of Electronic Publication: 2022 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/epidemiology
Adenocarcinoma*/etiology
Stomach Neoplasms*/complications
Stomach Neoplasms*/etiology
Aged ; Body Mass Index ; Case-Control Studies ; Humans ; Japan/epidemiology ; Male ; Obesity/complications ; Obesity/epidemiology ; Obesity, Abdominal/complications ; Obesity, Abdominal/epidemiology
Czasopismo naukowe
Tytuł :
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Autorzy :
Hu LT; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Deng WJ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Chu ZS; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Sun L; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Zhang CB; Department of Medical Technology, Collaborative Innovation Center for Translation Medical Testing and Application Technology Zhangzhou, Zhang Zhou Health Vocational College, Zhangzhou, 363000, Fujian Province, China.
Lu SZ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Weng JR; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Ren QS; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Dong XY; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li WD; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li XB; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Du YT; Department of Laboratory, Cancer Hospital of China Medical University, Shenyang,, Liaoning Province, China.
Li Y; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Wang WQ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Pokaż więcej
Źródło :
BMC pulmonary medicine [BMC Pulm Med] 2022 Jun 29; Vol. 22 (1), pp. 259. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study.
Autorzy :
Li J; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China.
Gao X; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China.
Dominik Nickel M; Siemens Healthcare GmbH, 91052, Erlangen, Germany.
Cheng J; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China. .
Zhu J; MR Collaboration, Siemens Healthcare Ltd, Beijing, 100000, China.
Pokaż więcej
Źródło :
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2022 Jun 17; Vol. 22 (1), pp. 30. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Adenocarcinoma, Mucinous*/diagnostic imaging
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/pathology
Diffusion Magnetic Resonance Imaging/methods ; Humans ; Pilot Projects ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.
Autorzy :
Sun Z; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zeng Y; Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yuan T; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang H; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ma X; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Institute of Molecular Medicine, Department of Laboratory Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogene and Related Genes, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2022 Jun 10; Vol. 13, pp. 906889. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Algorithms ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Humans ; Hypoxia/genetics ; Machine Learning
Czasopismo naukowe
Tytuł :
Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Autorzy :
Wu Q; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.; Department of Pulmonary and Critical Care Medicine, The Second Hospital of Shandong University, Jinan, 250033, China.
Li R; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Wang QX; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Zhang MY; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Liu TT; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Qu YQ; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China. .
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2022 Jun 07; Vol. 20 (1), pp. 260. Date of Electronic Publication: 2022 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Cell Adhesion Molecules/*metabolism
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Junctional Adhesion Molecules/genetics ; Junctional Adhesion Molecules/metabolism ; Wnt Signaling Pathway ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł :
Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report.
Autorzy :
Cao X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Liu X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Wang S; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Liu Z; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Ren X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Sun D; Institute of Biomedical Research, Genecast Biotechnology Co., Ltd, Wuxi, China.
Deng L; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2022 Jun; Vol. 50 (6), pp. 3000605221105368.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Male ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-ret/genetics ; Proto-Oncogene Proteins c-ret/therapeutic use ; Pyrazoles ; Pyridines ; Pyrimidines
Czasopismo naukowe
Tytuł :
Use of a highly sensitive lung cancer compact panel to detect KRAS G12D in the wash fluid from a lung tumor: A case report.
Autorzy :
Minami D; Department of Respiratory Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.; Department of Respiratory Medicine, Hosoya Hospital, Ibara, Japan.
Takigawa N; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.; Department of Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.
Nakajima Y; Department of Respiratory Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Miyahara N; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Mizumori Y; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Himeji, Japan.
Ueda M; Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Japan.
Nakamura S; DNA Chip Research Inc, Japan.
Suzuki F; DNA Chip Research Inc, Japan.
Sato Y; DNA Chip Research Inc, Japan.
Morikawa K; Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Kanehiro A; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Pokaż więcej
Źródło :
Thoracic cancer [Thorac Cancer] 2022 Jun; Vol. 13 (11), pp. 1735-1738. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Case Reports
MeSH Terms :
Adenocarcinoma of Lung*/genetics
Adenocarcinoma, Mucinous*/diagnosis
Adenocarcinoma, Mucinous*/genetics
Adenocarcinoma, Mucinous*/surgery
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Aged ; Bronchoscopy/methods ; Female ; Humans ; Image-Guided Biopsy/methods ; Proto-Oncogene Proteins p21(ras)/genetics
Raport
Tytuł :
Clinical relevance of PD-L2 expression in surgically resected lung adenocarcinoma.
Autorzy :
Takamochi K; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: .
Hara K; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hayashi T; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kohsaka S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Takahashi F; Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Suehara Y; Department of Orthopedic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Shimokawa M; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Suzuki K; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Jun; Vol. 168, pp. 50-58. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/surgery
Programmed Cell Death 1 Ligand 2 Protein/*metabolism
B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/metabolism ; ErbB Receptors/metabolism ; Humans ; Male ; Neoplasm Recurrence, Local ; Programmed Cell Death 1 Receptor/metabolism ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Receptor Protein-Tyrosine Kinases/genetics
Czasopismo naukowe
Tytuł :
TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Autorzy :
Wang J; Respiratory and Critical Care Medicine Department, The Second People's Hospital of Shaanxi Province, Xi'an, Shaanxi 710005, P.R. China.
Pan X; General Surgery Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Li J; Radiotherapy Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Zhao J; Radiotherapy Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Pokaż więcej
Źródło :
Molecular medicine reports [Mol Med Rep] 2022 Jun; Vol. 25 (6). Date of Electronic Publication: 2022 Apr 29.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Thioredoxins/*metabolism
14-3-3 Proteins/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Humans
Czasopismo naukowe
Tytuł :
Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report.
Autorzy :
Wang Y; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Li J; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Luo L; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Li X; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Liu Q; Department of Pathology, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Wang Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Che G; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xie X; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Pokaż więcej
Źródło :
Thoracic cancer [Thorac Cancer] 2022 Jun; Vol. 13 (11), pp. 1731-1734. Date of Electronic Publication: 2022 Apr 18.
Typ publikacji :
Case Reports
MeSH Terms :
Adenocarcinoma*/drug therapy
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Small Cell Lung Carcinoma*/drug therapy
Small Cell Lung Carcinoma*/pathology
Female ; Gefitinib/therapeutic use ; Humans ; Middle Aged
Raport
Tytuł :
MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung.
Autorzy :
Yamanoi K; Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan. .; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan. .
Fujii C; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.; Department of Biotechnology, Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto, 390-8621, Japan.
Yuzuriha H; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
Kumazawa M; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
Shimoda M; Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.; Department of Pathology, Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Emoto K; Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
Asamura H; Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Nakayama J; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
Pokaż więcej
Źródło :
Histochemistry and cell biology [Histochem Cell Biol] 2022 Jun; Vol. 157 (6), pp. 671-684. Date of Electronic Publication: 2022 Mar 30.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/metabolism
Adenocarcinoma, Mucinous*
Gastric Mucins/metabolism ; Humans ; Lung/metabolism ; Mucin 5AC/metabolism ; Mucin-6/analysis ; Mucin-6/metabolism ; Prognosis
Czasopismo naukowe
Tytuł :
Cribriform adenocarcinoma of the tongue and minor salivary glands: a systematic review of an uncommon clinicopathological entity.
Autorzy :
De Luca P; Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy. .
Tassone D; Otolaryngology Unit, San Giovanni-Addolorata Hospital, Rome, Italy.
de Campora L; Otolaryngology Unit, San Giovanni-Addolorata Hospital, Rome, Italy.
Simone M; Otolaryngology Unit, San Giovanni-Addolorata Hospital, Rome, Italy.
Marra P; Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Colacurcio V; Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Scarpa A; Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Costarelli L; Department of Pathology, San Giovanni-Addolorata Hospital, Rome, Italy.
Camaioni A; Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Pokaż więcej
Źródło :
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2022 Jun; Vol. 279 (6), pp. 2719-2725. Date of Electronic Publication: 2021 Oct 23.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Adenocarcinoma*/diagnosis
Adenocarcinoma*/pathology
Adenocarcinoma*/therapy
Salivary Gland Neoplasms*/diagnosis
Salivary Gland Neoplasms*/pathology
Salivary Gland Neoplasms*/therapy
Tongue Neoplasms*/pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Salivary Glands, Minor/pathology ; Tongue/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1.
Autorzy :
Fielder T; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Butler J; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Tierney G; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Holmes M; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Lam KY; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Satgunaseelan L; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Colebatch AJ; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Mahar A; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Gupta R; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, NSW, Australia.
O'Toole S; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, NSW, Australia.
Cooper WA; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, NSW, Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia. Electronic address: .
Pokaż więcej
Źródło :
Pathology [Pathology] 2022 Jun; Vol. 54 (4), pp. 399-403. Date of Electronic Publication: 2021 Oct 25.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/diagnosis
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Gene Rearrangement ; Humans ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism
Czasopismo naukowe
Tytuł :
Subsolid Lung Adenocarcinomas: Radiological, Clinical and Pathological Features and Outcomes.
Autorzy :
Lai J; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Li Q; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fu F; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Y; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Li Y; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Liu Q; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China. Electronic address: .
Chen H; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institution of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło :
Seminars in thoracic and cardiovascular surgery [Semin Thorac Cardiovasc Surg] 2022 Summer; Vol. 34 (2), pp. 702-710. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Lung Neoplasms*/surgery
Humans ; Retrospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic impact of spread through air spaces in lung adenocarcinoma.
Autorzy :
Mantovani S; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Pernazza A; Department of Medical-Surgical Sciences and Biotechnologies, University of Rome Sapienza, Rome, Italy.
Bassi M; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Amore D; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Vannucci J; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Poggi C; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Diso D; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
d'Amati G; Department of Radiological, Oncological and Pathological Sciences, University of Rome Sapienza, Rome, Italy.
Della Rocca C; Department of Radiological, Oncological and Pathological Sciences, University of Rome Sapienza, Rome, Italy.
Rendina EA; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Venuta F; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Anile M; Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy.
Pokaż więcej
Źródło :
Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2022 Jun 01; Vol. 34 (6), pp. 1011-1015.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*
Aged ; Humans ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Autorzy :
Ke J; Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Cui J; Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Yang X; Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Du X; Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Ma B; School of Rehabilitation Medicine, Capital Medical University, China Rehabilitation Research Center, Beijing 100068, China.
Yu L; Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 May 20; Vol. 25 (5), pp. 311-322.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Adenosine/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Methylation ; Tumor Microenvironment/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies